Insulet, Mayo Clinic get in on Glooko ’ s $35m Series C round

Insulet (NSDQ:PODD) and Mayo Clinic were among the new investors to get in on a $35 million Series C round for Glooko and its diabetes management platform. The round was led by new investor Georgian Partners, joined by Insulet and Mayo Clinic and existing backers Medtronic, Samsung, Canaan Partners and Social Capital, Mountain View, Calif.-based Glooko said. The proceeds are earmarked for expanding the company’s sales, marketing and development teams; boosting its commercial footprint in France, Germany, the U.K., Asia and the Middle East; and data analytics and AI development projects. Glooko’s platform is designed to integrate data from blood glucose monitors and other devices with either an Apple (NSDQ:AAPL) iPhone or Google (NSDQ:GOOG) Android application. Food intake, medication and insulin dosage can also be recorded to provide context for changes in blood glucose readings. Data from meters and devices is sent to Glooko’s cloud-based Population Tracker, where patients and providers alike can view and analyze the data, and make decisions about interventions and treatments. “This additional funding will help us to further our mission: to improve the lives of people with diabetes,” CEO Rick Altinger said in prepared remarks. “With this capital, we will accelerate our investments in clinical solutions that aim to increase medication adherence, provide personalized insights and prompts...
Source: Mass Device - Category: Medical Devices Authors: Tags: Diabetes Funding Roundup Wall Street Beat Glooko Insulet Medtronic Source Type: news

Related Links:

Conclusion: Our meta-analysis suggests that the prevalence of IDH is lower than 12% for both the EBPG and the Nadir #x3c;90 definition which is much lower than stated in most reviews.Am J Nephrol 2019;49:497 –506
Source: American Journal of Nephrology - Category: Neurology Source Type: research
ConclusionsNo evidence of an association between the use of metformin or statins and the incidence of breast cancer in women with T2D was found. Among insulin users, a slightly higher incidence of breast cancer was observed.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
TYPE 2 diabetes affects many different areas of the body including the eyes, kidneys and heart but many people are unaware of how type 2 diabetes affects their mouths. There is one painful symptom that may indicate you have the condition - this is the sign to look out for.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
CONCLUSIONS: Population studies indicate that the prevalence of diabetes has increased and that there are approximately two new cases per 100 people per year. Evidence is still scarce in the jungle and in rural populations. PMID: 31116335 [PubMed - in process]
Source: Revista Peruana de Medicina de Experimental y Salud Publica - Category: International Medicine & Public Health Tags: Rev Peru Med Exp Salud Publica Source Type: research
Conclusion: Compared to eyes treated with PRP, eyes treated with adjunctive IVB showed less significant post-treatment changes in RNFL thickness. PMID: 31114652 [PubMed]
Source: Journal of Ophthalmic and Vision Research - Category: Opthalmology Tags: J Ophthalmic Vis Res Source Type: research
Publication date: Available online 22 May 2019Source: Redox BiologyAuthor(s): Yachun Han, Xiaoxuan Xu, Chengyuan Tang, Peng Gao, Xianghui Chen, Xiaofen Xiong, Ming Yang, Shikun Yang, Xuejing Zhu, Shuguang Yuan, Fuyou Liu, Li Xiao, Yashpal S. Kanwar, Lin Sun
Source: Redox Biology - Category: Biology Source Type: research
ConclusionDuring the 3-year follow-up period, mortality and clinical complications in STBAD patients after TEVAR were significantly reduced in the T2DM group. For STBAD patients who undergo TEVAR, properly relaxing of blood glucose control requirements may be beneficial for their prognosis.
Source: Life Sciences - Category: Biology Source Type: research
Postinfectious glomerulonephritis (PIGN) is primarily a disease of childhood. It occurs after upper respiratory tract infection or skin infections. Streptococcus is the most common causative agent, but in the elderly, staphylococcus is the main culprit. In adults, PIGN is more common in immunocompromised patients, particularly diabetics and alcoholics. Here, we report the case of an elderly diabetic male who presented with severe acute kidney injury with active urinary sediment after acute gastroenteritis. Additional analyses revealed a very low serum C3 level and a normal serum C4 level. Renal biopsy showed diffuse prolif...
Source: Case Reports in Nephrology and Dialysis - Category: Urology & Nephrology Source Type: research
In this study, we present a case of a diabetic patient with complicated benign prostatic hyperplasia who presented with acute urinary retention along with bilateral hydronephrosis and acute kidney injury. He was treated with water vapor thermal therapy and subsequent urethral stenting, which alleviated his acute presentation and clinical symptoms. To the authors’ knowledge, there are no reported cases which highlight the use of water vapor thermal therapy in complicated benign prostatic hyperplasia.
Source: Urology Case Reports - Category: Urology & Nephrology Source Type: research
AbstractPurpose of ReviewChildren and adolescents with type 1 diabetes (T1D) spend much of their waking time in the school environment. However, there is limited empirical understanding of the challenges youth face in managing their T1D at school. There is even less literature focused on potential interventions to improve health or psychological outcomes in youth with T1D in this milieu. This review seeks to summarize the recent literature on diabetes T1D management in the school setting, including recommendations for care, barriers, and targets for intervention.Recent FindingsT1D organizations recommend strong collaborati...
Source: Current Diabetes Reports - Category: Endocrinology Source Type: research
More News: Diabetes | Endocrinology | France Health | Funding | Georgia Health | Germany Health | Health Insurance | Insulin | Insurance | Marketing | Middle East Health | Pharmaceuticals